To learn more from the group of academic, physician and communications experts who participated in the virtual roundtable, click here:

Survey Methodology

This survey was conducted online within the United States by Harris Interactive on behalf of GE Healthcare from October 15-17, 2012 among 2,133 adults ages 18 and older. This online survey is not based on a probability sample and therefore no estimate of theoretical sampling error can be calculated. For complete survey methodology, including weighting variables, please contact Crystal Chuckel.


GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Headquartered in the United Kingdom, GE Healthcare is an $18 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs over 50,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at

1 “Discussed health information online” means discussed on social media/online communities/message boards/forums in the past 12 months. 2 “Non-user” means not at all/somewhat likely to use social media/online communities/message boards/forums to discuss health in the future.

Copyright Business Wire 2010

If you liked this article you might like

GE Is 'One of the Toughest Stocks I've Ever Had to Deal With,' Jim Cramer Says

General Electric's New CEO Has One Easy Choice

Here Are Monday's Hottest Stocks as the Dow Reaches New Records

You Are Forgetting This Commonsense Investing Wisdom

GE Is Too Cheap to Sell, but Its Dividend Looks Too Shaky to Buy: Cramer